Drug General Information |
Drug ID |
D03EAQ
|
Former ID |
DNC001016
|
Drug Name |
N-hydroxysulfonamides
|
Indication |
Discovery agent
|
Investigative |
[1]
|
Formula |
C6H6INO3S
|
Target and Pathway |
Target(s) |
Carbonic anhydrase I |
Target Info |
Inhibitor |
[1]
|
Carbonic anhydrase IV |
Target Info |
Inhibitor |
[1]
|
Carbonic anhydrase II |
Target Info |
Inhibitor |
[1]
|
KEGG Pathway
|
Nitrogen metabolismhsa00910:Nitrogen metabolism
|
Proximal tubule bicarbonate reclamationhsa00910:Nitrogen metabolism
|
Proximal tubule bicarbonate reclamation
|
Collecting duct acid secretion
|
Gastric acid secretion
|
Pancreatic secretion
|
Bile secretion
|
NetPath Pathway
|
IL4 Signaling Pathway
|
EGFR1 Signaling Pathway
|
Pathway Interaction Database
|
C-MYB transcription factor network
|
PathWhiz Pathway
|
Gastric Acid Production
|
Reactome
|
Erythrocytes take up carbon dioxide and release oxygen
|
Erythrocytes take up oxygen and release carbon dioxide
|
Reversible hydration of carbon dioxideR-HSA-1237044:Erythrocytes take up carbon dioxide and release oxygen
|
Reversible hydration of carbon dioxide
|
WikiPathways
|
Reversible Hydration of Carbon Dioxide
|
Uptake of Carbon Dioxide and Release of Oxygen by Erythrocytes
|
Uptake of Oxygen and Release of Carbon Dioxide by ErythrocytesWP2770:Reversible Hydration of Carbon Dioxide
|
Uptake of Oxygen and Release of Carbon Dioxide by Erythrocytes
|
References |
REF 1 | Carbonic anhydrase inhibitors: inhibition of isozymes I, II and IV with N-hydroxysulfonamides--a novel class of intraocular pressure lowering agents. J Enzyme Inhib. 1998 Jul;13(4):267-84. |